The role of microRNA in modulating myocardial ischemia-reperfusion injury

Physiological Genomics

Volumn 43, Issue 10, 2011, Pages 534-542

  Ye, Yumei ^a   Perez Polo, Jose R ^a   Qian, Jinqiao ^a   Birnbaum, Yochai ^a,b,c  

^a University of Texas Medical Branch School of Medicine   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c ST LUKE S EPISCOPAL HOSPITAL   (United States)

Author keywords

Infarct size; Myocardial infarction

Indexed keywords

FAS LIGAND; HEAT SHOCK PROTEIN 20; HEAT SHOCK PROTEIN 60; HEAT SHOCK PROTEIN 70; MICRORNA; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN BCL 2; PROTEIN MCL 1; SIRTUIN 1;

HEART INFARCTION PREVENTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REPERFUSION INJURY; REVIEW; RNA SYNTHESIS;

ANIMALS; HUMANS; MICRORNAS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM;

EID: 79957631904     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00130.2010     Document Type: Review

References (51)

1. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, function. Cell 116: 281-297, 2004.
2. Bauersachs J, Thum T. MicroRNAs in the broken heart. Eur J Clin Invest 37: 829-833, 2007.
3. Birnbaum Y, Hale S.L, Kloner R.A. Ischemic preconditioning at a distance: reduction of myocardial infarct size by partial reduction of blood supply combined with rapid stimulation of the gastrocnemius muscle in the rabbit. Circulation 96: 1641-1646, 1997.
4. Bonauer A, Carmona G, Iwasaki M, Mione M, Koyanagi M, Fischer A, Burchfield J, Fox H, Doebele C, Ohtani K, Chavakis E, Potente M, Tjwa M, Urbich C, Zeiher A.M, Dimmeler S. MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 324: 1710-1713, 2009.
5. Bostjancic E, Zidar N, Stajer D, Glavac D. MicroRNAs miR-1, miR-133a, miR-133b and miR-208 are dysregulated in human myocardial infarction. Cardiology 115: 163-169, 2010.
6. Bostjancic E, Zidar N, Stajner D, Glavac D. MicroRNA miR-1 is up-regulated in remote myocardium in patients with myocardial infarction. Folia Biol (Praha) 56: 27-31, 2010.
7. Cheng Y, Ji R, Yue J, Yang J, Liu X, Chen H, Dean D.B, Zhang C. MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy? Am J Pathol 170: 1831-1840, 2007.
8. Cheng Y, Liu X, Zhang S, Lin Y, Yang J, Zhang C. MicroRNA-21 protects against the H2O2-induced injury on cardiac myocytes via its target gene PDCD4. J Mol Cell Cardiol 47: 5-14, 2009.
9. Cheng Y, Tan N, Yang J, Liu X, Cao X, He P, Dong X, Qin S, Zhang C. A translational study of circulating cell-free microRNA-1 in acute myocardial infarction. Clin Sci (Lond) 119: 87-95, 2010.
10. D'Alessandra Y, Devanna P, Limana F, Straino S, Di Carlo A, Brambilla P.G, Rubino M, Carena M.C, Spazzafumo L, De Simone M, Micheli B, Biglioli P, Achilli F, Martelli F, Maggiolini S, Marenzi G, Pompilio G, Capogrossi MC. Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. Eur Heart J (June 9, 2010). doi:10.1093/eurheartj/ehq167.
11. Divakaran V, Mann D.L. The emerging role of microRNAs in cardiac remodeling and heart failure. Circ Res 103: 1072-1083, 2008.
12. Dong S, Cheng Y, Yang J, Li J, Liu X, Wang X, Wang D, Krall T.J, Delphin E.S, Zhang C. MicroRNA expression signature and the role of microRNA-21 in the early phase of acute myocardial infarction. J Biol Chem 284: 29514-29525, 2009.
13. Harris T.A, Yamakuchi M, Ferlito M, Mendell J.T, Lowenstein C.J. MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc Natl Acad Sci USA 105: 1516-1521, 2008.
14. Horie T, Ono K, Nishi H, Nagao K, Kinoshita M, Watanabe S, Kuwabara Y, Nakashima Y, Takanabe-Mori R, Nishi E, Hasegawa K, Kita T, Kimura T. Acute doxorubicin cardiotoxicity is associated with miR-146a-induced inhibition of the neuregulin-ErbB pathway. Cardiovasc Res 87: 656-664, 2010.
15. Hutvagner G, McLachlan J, Pasquinelli A.E, Balint E, Tuschl T, Zamore P.D. A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 293: 834-838, 2001.
16. Keyes K.T, Xu J, Long B, Zhang C, Hu Z, Ye Y. Pharmacological inhibition of PTEN limits myocardial infarct size and improves left ventricular function postinfarction. Am J Physiol Heart Circ Physiol 298: H1198-H1208, 2010.
17. Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J, Lee J, Provost P, Radmark O, Kim S, Kim V.N. The nuclear RNase III Drosha initiates microRNA processing. Nature 425: 415-419, 2003.
18. Li Y, Li W, Yang Y, Lu Y, He C, Hu G, Liu H, Chen J, He J, Yu H. MicroRNA-21 targets LRRFIP1 and contributes to VM-26 resistance in glioblastoma multiforme. Brain Res 1286: 13-18, 2009.
19. Lin RJ, Lin YC, Yu AL. miR-149* induces apoptosis by inhibiting Akt1 and E2F1 in human cancer cells. Mol Carcinog 49: 719-727, 2010.
20. Lu H, Buchan R.J, Cook S.A. MicroRNA-223 regulates Glut4 expression and cardiomyocyte glucose metabolism. Cardiovasc Res 86: 410-420, 2010.
21. Mocanu M.M, Yellon D.M. PTEN, the Achilleśheel of myocardial ischaemia/reperfusion injury? Br J Pharmacol 150: 833-838, 2007.
22. Mott J.L, Kobayashi S, Bronk S.F, Gores GJ. mir-29 regulates Mcl-1 protein expression and apoptosis. Oncogene 26: 6133-6140, 2007.
23. Nakano H, Miyazawa T, Kinoshita K, Yamada Y, Yoshida T. Functional screening identifies a microRNA, miR-491 that induces apoptosis by targeting Bcl-XL in colorectal cancer cells. Int J Cancer 127: 1072- 1080, 2010.
24. Nishi H, Ono K, Iwanaga Y, Horie T, Nagao K, Takemura G, Kinoshita M, Kuwabara Y, Mori RT, Hasegawa K, Kita T, Kimura T. MicroRNA-15b modulates cellular ATP levels and degenerates mitochondria via Arl2 in neonatal rat cardiac myocytes. J Biol Chem 285: 4920-4930, 2010.
25. Papagiannakopoulos T, Shapiro A, Kosik K.S. MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. Cancer Res 68: 8164-8172, 2008.
26. Park S.Y, Lee J.H, Ha M, Nam J.W, Kim VN. miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42. Nat Struct Mol Biol 16: 23-29, 2009.
27. Perron M.P, Provost P. Protein interactions and complexes in human microRNA biogenesis and function. Front Biosci 13: 2537-2547, 2008.
28. Przyklenk K, Bauer B, Ovize M, Kloner R.A, Whittaker P. Regional ischemic "preconditioning" protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation 87: 893-899, 1993.
29. Rane S, He M, Sayed D, Vashistha H, Malhotra A, Sadoshima J, Vatner D.E, Vatner S.F, Abdellatif M. Downregulation of miR-199a derepresses hypoxia-inducible factor-1alpha and Sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes. Circ Res 104: 879- 886, 2009.
30. Ren X.P, Wu J, Wang X, Sartor M.A, Qian J, Jones K, Nicolaou P, Pritchard T.J, Fan G.C. MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20. Circulation 119: 2357-2366, 2009.
31. Roy S, Khanna S, Hussain S.R, Biswas S, Azad A, Rink C, Gnyawali S, Shilo S, Nuovo G.J, Sen C.K. MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metallopro-tease-2 via phosphatase and tensin homologue. Cardiovasc Res 82: 21-29, 2009.
32. Sayed D, He M, Hong C, Gao S, Rane S, Yang Z, Abdellatif M. MicroRNA-21 is a downstream effector of AKT that mediates its anti-apoptotic effects via suppression of Fas ligand. J Biol Chem 285: 20281-20290, 2010.
33. Sayed D, Hong C, Chen I.Y, Lypowy J, Abdellatif M. MicroRNAs play an essential role in the development of cardiac hypertrophy. Circ Res 100: 416-424, 2007.
34. Shaulian E, Karin M. AP-1 in cell proliferation and survival. Oncogene 20: 2390-2400, 2001.
35. Silvestri P, Di Russo C, Rigattieri S, Fedele S, Todaro D, Ferraiuolo G, Altamura G, Loschiavo P. MicroRNAs and ischemic heart disease: towards a better comprehension of pathogenesis, new diagnostic tools and new therapeutic targets. Recent Pat Cardiovasc Drug Discov 4: 109-118, 2009.
36. Tang Y, Zheng J, Sun Y, Wu Z, Liu Z, Huang G. MicroRNA-1 regulates cardiomyocyte apoptosis by targeting Bcl-2. Int Heart J 50: 377-387, 2009.
37. Thum T, Galuppo P, Wolf C, Fiedler J, Kneitz S, van Laake L.W, Doevendans P.A, Mummery C.L, Borlak J, Haverich A, Gross C, Engelhardt S, Ertl G, Bauersachs J. MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure. Circulation 116: 258- 267, 2007.
38. Thum T, Gross C, Fiedler J, Fischer T, Kissler S, Bussen M, Galuppo P, Just S, Rottbauer W, Frantz S, Castoldi M, Soutschek J, Kotelian-sky V, Rosenwald A, Basson M.A, Licht J.D, Pena J.T, Rouhanifard S.H, Muckenthaler M.U, Tuschl T, Martin G.R, Bauersachs J, Engelhardt S. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456: 980-984, 2008.
39. van Rooij E, Olson EN. MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets. J Clin Invest 117: 2369-2376, 2007.
40. van Rooij E, Sutherland L.B, Qi X, Richardson J.A, Hill J, Olson E.N. Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 316: 575-579, 2007.
41. van Rooij E, Sutherland L.B, Thatcher JE, DiMaio JM, Naseem R.H, Marshall W.S, Hill J.A, Olson E.N. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci USA 105: 13027-13032, 2008.
42. Viappiani S, Nicolescu A.C, Holt A, Sawicki G, Crawford B.D, Leon H, van Mulligen T, Schulz R. Activation and modulation of 72kDa matrix metalloproteinase-2 by peroxynitrite and glutathione. Biochem Pharmacol 77: 826-834, 2009.
43. Wang S, Aurora A.B, Johnson B.A, Qi X, McAnally J, Hill J.A, Richardson J.A, Bassel-Duby R, Olson E.N. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell 15: 261-271, 2008.
44. Xu C, Lu Y, Pan Z, Chu W, Luo X, Lin H, Xiao J, Shan H, Wang Z, Yang B. The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis by targeting HSP60, HSP70 and caspase-9 in cardiomyocytes. J Cell Sci 120: 3045-3052, 2007.
45. Yang B, Lin H, Xiao J, Lu Y, Luo X, Li B, Zhang Y, Xu C, Bai Y, Wang H, Chen G, Wang Z. The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat Med 13: 486-491, 2007.
46. Yang H, Kong W, He L, Zhao J.J, O'Donnell J.D, Wang J, Wenham R.M, Coppola D, Kruk P.A, Nicosia S.V, Cheng J.Q. MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res 68: 425-433, 2008.
47. Ye Y, Hu Z, Lin Y, Zhang C, Perez-Polo J.R. Downregulation of microRNA-29 by antisense inhibitors and a PPAR-gamma agonist protects against myocardial ischaemia-reperfusion injury. Cardiovasc Res 87: 535-544, 2010.
48. Ye Y, Lin Y, Manickavasagam S, Perez-Polo J.R, Tieu B.C, Birnbaum Y. Pioglitazone protects the myocardium against ischemia-reperfusion injury in eNOS and iNOS knockout mice. Am J Physiol Heart Circ Physiol 295: H2436-H2446, 2008.
49. Ye Y.M, Lin Y, Atar S, Huang M.H, Perez-Polo J.R, Uretsky B.F, Birnbaum Y. Myocardial protection by pioglitazone, atorvastatin, and their combination: mechanisms and possible interactions. Am J Physiol Heart Circ Physiol 291: H1158-H1169, 2006.
50. Yin C, Salloum F.N, Kukreja R.C. A novel role of microRNA in late preconditioning: upregulation of endothelial nitric oxide synthase and heat shock protein 70. Circ Res 104: 572-575, 2009.
51. Zernecke A, Bidzhekov K, Noels H, Shagdarsuren E, Gan L, Denecke B, Hristov M, Koppel T, Jahantigh M.N, Lutgens E, Wang S, Olson E.N, Schober A, Weber C. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci Signal 2: ra81, 2009.